Marc Limacher MBA
Marc Limacher started I.S.I.S. in 1992 as a boutique primary CI specialty firm focusing strictly on the pharma/biotech (12 therapy areas, medical devices/diagnostics, telehealth) and IT industries (including cloud infrastructure & software, enterprise software & applications across 10 industry verticals, social media, hardware, & IT services).
As a 25-year veteran in the CI and counter-intelligence industry, he has grown INOVIS into a global leader in primary regulatory, commercial and clinical intelligence & strategic consulting services, counting a select group of global Blue Chip companies as loyal clients. The introduction of an expert regulatory intelligence practice is unique in the industry.
Prior to INOVIS, Marc was Director of Market Intelligence at a leading U.S. institutional investment firm for five years, providing primary intelligence on small-/medium-/large-cap life science equities via a global employee network of 125 investigative journalists. He also delivers private CI seminars and is a frequent lecturer on CI and counter-intelligence topics at companies and to academia.
Marc is fluent in 5 languages and enjoys the proximity to the ski slopes from the Lucerne office, the proximity to the Pacific waves from the Palo Alto office, and the proximity to NYC from the Princeton office.